Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Rituxan (rituximab, Mabthera)
Rituximab (rituxan and mabthera) is a drug used to treat rheumatoid arthritis that has no longer progressed with different varieties of medicinal drugs, in addition to sure sorts of vasculitis. It works via turning off a part of the immune device that isn't always operating nicely in autoimmune illnesses. Rituximab is a monoclonal antibody that is a sort of targeted drug.In the cause of the treatment of rheumatoid arthritis, rituximab is used when other biologic medications (tnf-blockers, which include infliximab, [Remicade] etanercept [Enbrel], or adalimumab [Humira]) have did not be powerful.Rituximab is a remedy for persistent lymphocytic leukaemia (CLL) and a few types of non-hodgkin lym...
Rituximab
Rituximab (MabThera®, Rituxan®) is a chimaeric murine/human antibody targeted against the surface antigen CD20 that is expressed on normal and malignant human mature B cells, but not stem cells or plasma cells. It is potentially the proverbial magic bullet for diseases associated with B cell disorders as well as a probe for elucidating the role of B cells in health and disease. This book explores the full spectrum of activity of Rituximab in man.
Prevention
Prevention magazine provides smart ways to live well with info and tips from experts on weight loss, fitness, health, nutrition, recipes, anti-aging & diets.
Rituximab-mediated Molecular Signaling and Interactions with Chemotherapeutic Drugs
For several decades, cancer treatment relied on surgery, chemotherapy and radiation. The most widely used chemotherapy treatment in various cancers is based on the activities of these drugs to inhibit cell proliferation and induce cell death. While the clinical response rates have been very good, many patients experience recurrences and relapses and such patients become refractory to further treatments. Hence, there is an immediate need for the development of new treatment modalities. Currently, we have experienced the development of tumor specific targeted drugs that are more selective and less toxic. Immunotherapy against cancer has been validated experimentally in animal models bearing va...
Avoiding Common Nursing Errors
This handbook succinctly describes over 500 common errors made by nurses and offers practical, easy-to-remember tips for avoiding these errors. Coverage includes the entire scope of nursing practice—administration, medications, process of care, behavioral and psychiatric, cardiology, critical care, endocrine, gastroenterology and nutrition, hematology-oncology, infectious diseases, nephrology, neurology, pulmonary, preoperative, operative, and postoperative care, emergency nursing, obstetrics and gynecology, and pediatric nursing. The book can easily be read immediately before the start of a rotation or used for quick reference. Each error is described in a quick-reading one-page entry that includes a brief clinical scenario and tips on how to avoid or resolve the problem. Illustrations are included where appropriate.
Racing to a Cure
Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories. Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a...
